cola lipid c efficacy against candida albicans Targeting Azole-Resistant albicans: Tetrapeptide Tuftsin-Modified Liposomal Vaccine Induces Superior Immune Protection Celastrol boosts fluconazole efficacy against
Celastrol boosts fluconazole efficacy against vaginal candidiasis: in vitro and in vivo evidence AMB Express Springer Nature Link Candida albicans accelerates atherosclerosis by activating intestinal hypoxia inducible factor2 signaling ScienceDirect Candida albicans gains azole resistance by altering sphingolipid composition Nature Communications Antimicrobial Activity of the Peptide C14R Against Ab Initio Growing and Preformed Biofilms of Candida albicans, Candida parapsilosis and Candidozyma auris
Pay in 4 interest-free payments of $6.57 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 2 - Aug 7



